Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Tech Weekly: Chip Stocks Pop to Close Volatile... February 7, 2026 Tartisan Nickel Corp. February 12, 2026 Trump’s Nuclear Revival Plan Boosts Uranium Prices, Sends... May 30, 2025 Blue Lagoon Resources Officially Opens Dome Mountain Gold... July 12, 2025 Lo Herma Hydrogeology Testing & Resource Expansion Drilling September 18, 2025 Gold Fields Completes AU$3.7 Billion Acquisition of Gold... October 20, 2025 Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due... April 26, 2025 Ian Rodger Appointed Managing Director July 1, 2025 Crypto Market Update: Trump’s Tariff Reset Jolts Bitcoin... February 24, 2026 Dr. Adam Trexler: Physical Gold Market Broken, Crisis... February 10, 2026
